Research demonstrates that FGFR expression remains more stable in highly aggressive tumors, and FGFR3 overexpression or aberrant activation of other FGFR family members (e.g., FGFR1) can promote tumor progression and metastasis via ligand-dependent mechanisms (12). Here, FGFR3 is linked to neoplasm.